JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential ...Middle East

PR Newswire - News
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently, most cancer diagnosis is done through thinly sliced...

Hence then, the article about jellox biotech leads research in 3d cancer pathology as nci explores potential was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential )

Apple Storegoogle play

Last updated :

Also on site :